Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 508 clinical trials
None
Functional Precision Oncology for Metastatic Breast Cancer

This is a pilot study to assess the feasibility of comprehensive genomic characterization and drug screening in metastatic breast cancer. The trial will seek to provide personalized genomic and drug sensitivity information to eligible patients with metastatic breast cancer prior to disease progression on standard treatment. The trial will also …

  • 0 views
  • 19 Apr, 2021
  • 1 location
None
Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)

This is a prospective, single center, randomized, open-labled stage III clinical trial comparing the efficacy and safety of anthracyclin followed by weekly paclitaxel versus dose-dense anthracyclin followed by weekly paclitaxel versus dose-dense anthracyclin followed by weekly paclitaxel combined with carboplatin for high-risk, triple-negative early breast cancer.

ki-67
cancer
epirubicin
blood transfusion
carboplatin
  • 20 views
  • 23 Jan, 2021
  • 1 location
None
Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)

patients with triple-negative breast cancer. Patients with stage II/III operable triple-negative breast cancer are eligible. Patients who need adjuvant chemotherapy after breast surgery as well as

female breast cancer
anthracyclines
adjuvant chemotherapy
adjuvant therapy
core needle biopsy
  • 82 views
  • 23 Jan, 2021
  • 12 locations
None
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

The current study is designed to evaluate the efficacy and safety of AL101 monotherapy in subjects with Notch-activated recurrent or metastatic TNBC; Notch activation will be determined by a Next Generation Sequencing (NGS) test.

cancer
progesterone
formalin-fixed paraffin-embedded
parp inhibitor
metastasis
  • 0 views
  • 20 Oct, 2021
  • 28 locations
None
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

metastatic triple negative breast cancer

cancer
trastuzumab
antineoplastic
HER2
paclitaxel
  • 400 views
  • 03 Nov, 2021
  • 65 locations
None
Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

This is a prospective, multicenter, randomized, parallel controlled, open-label study. The primary purpose of this study is to evaluate the efficacy of Huaier Granule on postoperative adjuvant therapy of high-risk early-stage triple-negative invasive ductal carcinoma. The Secondary purposes are to evaluate the safety of long-term use of Huaier granules as …

tumor cells
ductal carcinoma
metastasis
carcinoma
  • 0 views
  • 29 Jul, 2021
  • 1 location
None
Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer

docetaxel (EC4-T4) verses 6 cycles of weekly paclitaxel combined with carboplatin (PCb*6) in the adjuvant chemotherapy of non-triple negative breast cancer patients. The study is divided in to 2

estrogen receptor
adjuvant chemotherapy
epirubicin
progesterone
erbb2
  • 2 views
  • 23 Jan, 2021
  • 1 location
None
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Triple-negative breast cancer (TNBC) accounts for about 20% of clinical breast cancer. Clinical characteristics include early onset, high malignancy and heterogeneity. There is no effective drug

epidermal growth factor receptor
estrogen receptor
progesterone
metastasis
epidermal growth factor
  • 0 views
  • 31 Jul, 2021
  • 1 location
None
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

(EC-TCb) in triple-negative breast cancer.

estrogen receptor
adjuvant chemotherapy
epirubicin
progesterone
erbb2
  • 90 views
  • 24 Jan, 2021
  • 27 locations
None
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

triple-negative breast cancer patients with Locally Advanced or Metastatic Breast Cancer. Patients will continue the treatment in the absence of disease progression and unacceptable toxicity. Disease

chemotherapy regimen
docetaxel
cancer
triple-negative breast cancer
solid tumour
  • 56 views
  • 24 Jan, 2021
  • 4 locations